Another successful registration project in the Republic of Kazakhstan was drug Neuroxon in the tablet form. NEUROXON is a medicine used in the treatment of: strokes and the consequences; brain injury and its consequences; cognitive, sensory and motor neurological disorders caused by degenerative and vascular disorders of the brain. Neuroxon was registered in the dosage of 500 mg, No. 20 and No. 30.